ArticleTherapeutic advances in hematology2026

Assessment of flonoltinib maleate versus ruxolitinib phosphate in intermediate- to high-risk myelofibrosis (FMF-02): study protocol for a multicenter, randomized, open-label phase IIB trial.

Linyu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.